Aeterna Zentaris Inc(NASDAQ:AEZS) 
Aeterna Zentaris Inc., a specialty biopharmaceutical company, engages in developing and commercializing therapeutics and diagnostic tests. Its lead product is macimorelin, a peptidomimetic ghrelin receptor (GHSR-1a) agonist that stimulates the secretion of growth hormone by binding to the GHSR-1a fo...
Website: http://www.zentaris.com
Founded: 1990
CEO: David Mazzo
Sector: Healthcare
Industry: Biotechnology
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-03-06
P
O 2.78
H 2.90
L 2.71
C 2.72
V 6,439
10EMA 2.72
20EMA 2.72
60EMA 2.72
120EMA 2.72
250EMA 2.72